![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 13, 2017 11:19:45 PM
When Brilacidin was first obtained by CTIX, the talk was how it had to be saved as a precious last resort drug for the terrible afflictions like ABSSI and perhaps those other flesh eating organisms. CTIX had to be careful not to overexpose our precious molecule, lest it fall prey to "resistance" development by the organism(s) being treated. Based on those assumptions I was under the impression that even "swish and spit" would not be into a sink, but into a special container so that the contents could later be boiled to eliminate any possible remaining organisms surviving and coming back later and resistant.
I recently watched the PBS documentary THE FORGOTTEN PLAGUE which was about fighting tuberculosis in the U.S. from 1910 to 1950. When Penicillin first came out in early 1940s it was found to be very effective in "curing" TB. But within 4 years, it became useless against TB because of resistance developed.
I hope IPIX management is keeping this issue in mind.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM